Relaxin-3/RXFP3 signaling and neuroendocrine function - A perspective on extrinsic hypothalamic control

Frontiers in Endocrinology

Volumn 4, Issue SEP, 2013, Pages

  Ganella, Despina E ^a   Ma, Sherie ^a   Gundlach, Andrew L ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Arginine vasopressin; CRH; Feeding; Metabolism; Oxytocin; Relaxin 3; Reproduction; Stress

Indexed keywords

EID: 84886022824     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00128     Document Type: Review

References (128)

1. Herman JP, Cullinan WE, Ziegler DR, Tasker JG. Role of the paraventricular nucleus microenvironment in stress integration. Eur J Neurosci (2002) 16:381-5. doi:10.1046/j.1460-9568.2002.02133.x.
2. Small CJ, Stanley SA, Bloom SR. Appetite control and reproduction:leptin and beyond. Semin Reprod Med (2002) 20:389-98. doi:10.1055/s-2002-36712.
3. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature (2006) 443:289-95. doi:10.1038/nature05026.
4. Gao Q, Horvath TL. Neurobiology of feeding and energy expenditure. Annu Rev Neurosci (2007) 30:367-98. doi:10.1146/annurev.neuro.30.051606.094324.
5. Adamantidis A, de Lecea L. Physiological arousal:a role for hypothalamic systems. Cell Mol Life Sci (2008) 65:1475-88. doi:10.1007/s00018-008-7521-8.
6. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci (2009) 10:397-409. doi:10.1038/nrn2647.
7. Zeltser LM, Seeley RJ, Tschöp MH. Synaptic plasticity in neuronal circuits regulating energy balance. Nat Neurosci (2012) 15:1336-42. doi:10.1038/nn.3219.
8. Lantos TA, Görcs TJ, Palkovits M. Immunohistochemical mapping of neuropeptides in the premamillary region of the hypothalamus in rats. Brain Res Rev (1995) 20:209-49. doi:10.1016/0165-0173(94)00013-F.
9. Broberger C, De Lecea L, Sutcliffe JG, Hokfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus:relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol (1998) 402:460-74. doi:10.1002/(SICI)1096-9861(19981228)402:4<460::AID-CNE3>3.3.CO;2-J.
10. Carlin KM, Vale WW, Bale TL. Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis. Proc Natl Acad Sci U S A (2006) 103:3462-7. doi:10.1073/pnas.0511320103.
11. Lechan RM, Fekete C. The TRH neuron:a hypothalamic integrator of energy metabolism. Prog Brain Res (2006) 153:209-35. doi:10.1016/S0079-6123(06)53012-2.
12. Meister B. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol Behav (2007) 92:263-71. doi:10.1016/j.physbeh.2007.05.021.
13. Sakurai T. The neural circuit of orexin (hypocretin):maintaining sleep and wakefulness. Nat Rev Neurosci (2007) 8:171-81. doi:10.1038/nrn2092.
14. Saito Y, Nagasaki H. The melanin-concentrating hormone system and its physiological functions. Results Probl Cell Differ (2008) 46:159-79. doi:10.1007/400_2007_052.
15. Williams KW, Elmquist JK. Lighting up the hypothalamus:coordinated control of feeding behavior. Nat Neurosci (2011) 14:277-8. doi:10.1038/nn0311-277.
16. Parker JA, Bloom SR. Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology (2012) 63:18-30. doi:10.1016/j.neuropharm.2012.02.004.
17. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, et al. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev (1998) 50:143-50.
18. Bale TL, Vale WW. CRF and CRF receptors:role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol (2004) 44:525-57. doi:10.1146/annurev.pharmtox.44.101802.121410.
19. Alexander SP, Mathie A, Peters JA. Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol (2011) 164(Suppl 1):S1-324. doi:10.1111/j.1476-5381.2011.01649_1.x.
20. Hazell GG, Hindmarch CC, Pope GR, Roper JA, Lightman SL, Murphy D, et al. G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei-serpentine gateways to neuroendocrine homeostasis. Front Neuroendocrinol (2012) 33:45-66. doi:10.1016/j.yfrne.2011.07.002.
21. Knobloch HS, Charlet A, Hoffmann LC, Eliava M, Khrulev S, Cetin AH, et al. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron (2012) 73:553-66. doi:10.1016/j.neuron.2011.11.030.
22. Krashes MJ, Koda S, Ye CP, Rogan SC, Adarns AC, Cusher DS, et al. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J Clin Invest (2011) 121:1424-8. doi:10.1172/JCI46229.
23. Atasoy D, Betley JN, Su HH, Sternson SM. Deconstruction of a neural circuit for hunger. Nature (2012) 488:172-7. doi:10.1038/nature11270.
24. de Lecea L, Carter ME, Adamantidis A. Shining light on wakefulness and arousal. Biol Psychiatry (2012) 71:1046-52. doi:10.1016/j.biopsych.2012.01.032.
25. Zhan C, Zhou JF, Feng QR, Zhang JE, Lin SL, Bao JH, et al. Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively. J Neurosci (2013) 33:3624-32. doi:10.1523/JNEUROSCI.2742-12.2013.
26. Bathgate RAD, Samuel CS, Burazin TCD, Layfield S, Claasz AA, Reytomas IGT, et al. Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene:novel members of the relaxin peptide family. J Biol Chem (2002) 277:1148-57. doi:10.1074/jbc. M107882200.
27. Ma S, Gundlach AL. Relaxin-family peptide and receptor systems in brain:insights from recent anatomical and functional studies. Adv Exp Med Biol (2007) 612:119-37. doi:10.1007/978-0-387-74672-2_9.
28. Bathgate RAD, Halls ML, van der Westhuizen ET, Callander GE, Kocan M, Summers RJ. Relaxin family peptides and their receptors. Physiol Rev (2013) 93:405-80. doi:10.1152/physrev.00001.2012.
29. Burazin TCD, Bathgate RAD, Macris M, Layfield S, Gundlach AL, Tregear GW. Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain. J Neurochem (2002) 82:1553-7. doi:10.1046/j.1471-4159.2002.01114.x.
30. Liu C, Eriste E, Sutton S, Chen J, Roland B, Kuei C, et al. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein coupled receptor GPCR135. J Biol Chem (2003) 278:50754-64. doi:10.1074/jbc. M308995200.
31. Bathgate RAD, Ivell R, Sanborn BM, Sherwood OD, Summers RJ. International Union of Pharmacology LVII:recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev (2006) 58:7-31. doi:10.1124/pr.58.1.9.
32. Sutton SW, Bonaventure P, Kuei C, Roland B, Chen J, Nepomuceno D, et al. Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing. Neuroendocrinology (2004) 80:298-307. doi:10.1159/000083656.
33. Ma S, Bonaventure P, Ferraro T, Shen PJ, Burazin TCD, Bathgate RAD, et al. Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat. Neuroscience (2007) 144:165-90. doi:10.1016/j.neuroscience.2006.08.072.
34. Smith CM, Shen PJ, Banerjee A, Bonaventure P, Ma S, Bathgate RAD, et al. Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain. J Comp Neurol (2010) 518:4016-45. doi:10.1002/cne.22442.
35. Ma S, Sang Q, Lanciego JL, Gundlach AL. Localization of relaxin-3 in brain of Macaca fascicularis-identification of nucleus incertus in primate. J Comp Neurol (2009) 517:856-72. doi:10.1002/cne.22197.
36. Ma S, Shen P-J, Sang Q, Lanciego JL, Gundlach AL. Distribution of relaxin-3 mRNA and immunoreactivity, and RXFP3 binding sites in the brain of the macaque, Macaca fascicularis. Ann N Y Acad Sci (2009) 1160:256-8. doi:10.1111/j.1749-6632.2009.03954.x.
37. Hsu SYT. New insights into the evolution of the relaxin-LGR signaling system. Trends Endocrinol Metab (2003) 14:303-9. doi:10.1016/S1043-2760(03)00106-1.
38. Wilkinson TN, Speed TP, Tregear GW, Bathgate RAD. Evolution of the relaxin-like peptide family. BMC Evol Biol (2005) 5:14. doi:10.1186/1471-2148-5-14.
39. Smith CM, Ryan PJ, Hosken IT, Ma S, Gundlach AL. Relaxin-3 systems in the brain-the first 10 years. J Chem Neuroanat (2011) 42:262-75. doi:10.1016/j.jchemneu.2011.05.013.
40. Bathgate RAD, Lin F, Hanson NF, Otvos LJ, Guidolin A, Giannakis C, et al. Relaxin-3:improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry (2006) 45:1043-53. doi:10.1021/bi052233e.
41. Hossain MA, Smith CM, Ryan PJ, Büchler E, Bathgate RAD, Gundlach AL, et al. Chemical synthesis and orexigenic activity of rat/mouse relaxin-3. Amino Acids (2013) 44:1529-36. doi:10.1007/s00726-013-1478-0.
42. Sherwood OD. Relaxin's physiological roles and other diverse actions. Endocr Rev (2004) 25:205-34. doi:10.1210/er.2003-0013.
43. Ganella DE, Callander GE, Ma S, Bye CR, Gundlach AL, Bathgate RAD. Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus. Gene Ther (2013) 20:703-16. doi:10.1038/gt.2012.83.
44. Goto M, Swanson LW, Canteras NS. Connections of the nucleus incertus. J Comp Neurol (2001) 438:86-122. doi:10.1002/cne.1303.
45. Olucha-Bordonau FE, Teruel V, Barcia-Gonzalez J, Ruiz-Torner A, Valverde-Navarro AA, Martinez-Soriano F. Cytoarchitecture and efferent projections of the nucleus incertus of the rat. J Comp Neurol (2003) 464:62-97. doi:10.1002/cne.10774.
46. Tanaka M, Iijima N, Miyamoto Y, Fukusumi S, Itoh Y, Ozawa H, et al. Neurons expressing relaxin 3/INSL7 in the nucleus incertus respond to stress. Eur J Neurosci (2005) 21:1659-70. doi:10.1111/j.1460-9568.2005.03980.x.
47. Ma S, Olucha-Bordonau FE, Hossain MA, Lin F, Kuei C, Liu C, et al. Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus. Learn Mem (2009) 16:730-42. doi:10.1101/lm.1438109.
48. Teruel-Marti V, Cervera-Ferri A, Nunez A, Valverde-Navarro AA, Olucha-Bordonau FE, Ruiz-Torner A. Anatomical evidence for a ponto-septal pathway via the nucleus incertus in the rat. Brain Res (2008) 1218:87-96. doi:10.1016/j.brainres.2008.04.022.
49. Cervera-Ferri A, Rahmani Y, Martínez-Bellver S, Teruel-Martí V, Martínez-Ricós J. Glutamatergic projection from the nucleus incertus to the septohippocampal system. Neurosci Lett (2012) 517:71-6. doi:10.1016/j.neulet.2012.04.014.
50. Olucha-Bordonau FE, Otero-García M, Sánchez-Pérez AM, Núñez A, Ma S, Gundlach AL. Distribution and targets of the relaxin-3 innervation of the septal area in the rat. J Comp Neurol (2012) 520:1903-39. doi:10.1002/cne.23018.
51. Banerjee A, Shen PJ, Ma S, Bathgate RAD, Gundlach AL. Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation. Neuropharmacology (2010) 58:145-55. doi:10.1016/j.neuropharm.2009.06.019.
52. Ryan PJ, Ma S, Olucha-Bordonau FE, Gundlach AL. Nucleus incertus-an emerging modulatory role in arousal, stress and memory. Neurosci Biobehav Rev (2011) 35:1326-41. doi:10.1016/j.neubiorev.2011.02.004.
53. Ma S, Blasiak A, Olucha-Bordonau FE, Verberne AJM, Gundlach AL. Heterogeneous responses of nucleus incertus neurons to corticotropin-releasing factor and coherent activity with hippocampal theta rhythm. J Physiol (2013) 591:3981-4001. doi:10.1113/jphysiol.2013.254300.
54. Blasiak A, Blasiak T, Hossain MA, Wade JD, Gundlach AL. Relaxin-3 innervation and modulation of the intergeniculate leaflet of the rat thalamus. Neuropeptides (2009) 43:430.
55. Blasiak A, Blasiak T, Lewandowski MH, Hossain MA, Wade JD, Gundlach AL. Relaxin-3 innervation of the intergeniculate leaflet of the rat thalamus-neuronal tract-tracing and in vitro electrophysiological studies. Eur J Neurosci (2013) 37:1284-94. doi:10.1111/ejn.12155.
56. Morin LP, Allen CN. The circadian visual system, 2005. Brain Res Rev (2006) 51:1-60. doi:10.1016/j.brainresrev.2005.08.003.
57. Delogu A, Sellers K, Zagoraiou L, Bocianowska-Zbrog A, Mandal S, Guimera J, et al. Subcortical visual shell nuclei targeted by ipRGCs develop from a Sox14+-GABAergic progenitor and require Sox14 to regulate daily activity rhythms. Neuron (2012) 75:648-62. doi:10.1016/j.neuron.2012.06.013.
58. Morin LP. Neuroanatomy of the extended circadian rhythm system. Exp Neurol (2013) 243:4-20. doi:10.1016/j.expneurol.2012.06.026.
59. Ziegler DR, Edwards MR, Ulrich-Lai YM, Herman JP, Cullinan WE. Brainstem origins of glutamatergic innervation of the rat hypothalamic paraventricular nucleus. J Comp Neurol (2012) 520:2369-94. doi:10.1002/cne.23043.
60. Boels K, Hermans-Borgmeyer I, Schaller HC. Identification of a mouse orthologue of the G-protein-coupled receptor SALPR and its expression in adult mouse brain and during development. Dev Brain Res (2004) 152:265-8. doi:10.1016/j.devbrainres.2004.06.002.
61. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RA, et al. H3 Relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J Biol Chem (2003) 278:7855-62. doi:10.1074/jbc. M212457200.
62. Ma S, Shen P-J, Burazin TCD, Tregear GW, Gundlach AL. Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [33P]-relaxin binding sites in rat brain:restricted somatic co-expression a clue to relaxin action? Neuroscience (2006) 141:329-44. doi:10.1016/j.neuroscience.2006.03.076.
63. van der Westhuizen ET, Werry TD, Sexton PM, Summers RJ. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism. Mol Pharmacol (2007) 71:1618-29. doi:10.1124/mol.106.032763.
64. Liu C, Chen J, Sutton S, Roland B, Kuei C, Farmer N, et al. Identification of relaxin-3/INSL7 as a ligand for GPCR142. J Biol Chem (2003) 278:50765-70. doi:10.1074/jbc. M308996200.
65. Liu C, Chen J, Kuei C, Sutton S, Nepomuceno D, Bonaventure P, et al. Relaxin-3/Insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Mol Pharmacol (2005) 67:231-40. doi:10.1124/mol.104.006700.
66. McGowan BM, Stanley SA, Smith KL, White NE, Connolly MM, Thompson EL, et al. Central relaxin-3 administration causes hyperphagia in male wistar rats. Endocrinology (2005) 146:3295-300. doi:10.1210/en.2004-1532.
67. McGowan BM, Stanley SA, Smith KL, Minnion JS, Donovan J, Thompson EL, et al. Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul Pept (2006) 136:72-7. doi:10.1016/j.regpep.2006.04.009.
68. Otsubo H, Onaka T, Suzuki H, Katoh A, Ohbuchi T, Todoroki M, et al. Centrally administered relaxin-3 induces Fos expression in the osmosensitive areas in rat brain and facilitates water intake. Peptides (2010) 31:1124-30. doi:10.1016/j.peptides.2010.02.020.
69. Watanabe Y, Miyamoto Y, Matsuda T, Tanaka M. Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus. J Mol Neurosci (2011) 43:169-74. doi:10.1007/s12031-010-9468-0.
70. Nakazawa C, Shikata K, Uesugi M, Katayama H, Aoshima K, Tahara K, et al. Prediction of relaxin-3-induced downstream pathway resulting in anxiolytic-like behaviors in rats based on a microarray and peptidome analysis. J Recept Signal Transduct Res (2013) 33:224-33. doi:10.3109/10799893.2012.756895.
71. McGowan BM, Stanley SA, Donovan J, Thompson EL, Patterson M, Semjonous NM, et al. Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis. Am J Physiol Endocrinol Metab (2008) 295:E278-86. doi:10.1152/ajpendo.00028.2008.
72. Kuei C, Sutton S, Bonaventure P, Pudiak C, Shelton J, Zhu J, et al. R3(Bd23-27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7:in vitro and in vivo characterization. J Biol Chem (2007) 282:25425-35. doi:10.1074/jbc. M701416200.
73. Haugaard-Kedstrom LM, Shabanpoor F, Hossain MA, Clark RJ, Ryan PJ, Craik DJ, et al. Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3. J Am Chem Soc (2011) 133:4965-74. doi:10.1021/ja110567j.
74. Shabanpoor F, Hossain MA, Ryan PJ, Belgi A, Layfield S, Kocan M, et al. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1. J Med Chem (2012) 55:1671-81. doi:10.1021/jm201505p.
75. Dietrich MO, Horvath TL. Feeding signals and brain circuitry. Eur J Neurosci (2009) 30:1688-96. doi:10.1111/j.1460-9568.2009.06963.x.
76. Ganella DE, Ryan PJ, Bathgate RAD, Gundlach AL. Increased feeding and body weight gain after acute/chronic hypothalamic activation of RXFP3 by relaxin-3 and receptor-selective synthetic and rAAV-driven agonist peptides:functional and therapeutic implications. Behav Pharmacol (2012) 23:516-25. doi:10.1097/FBP.0b013e3283576999.
77. Stanley BG, Daniel DR, Chin AS, Leibowitz SF. Paraventricular nucleus injections of peptide-YY and neuropeptide-Y preferentially enhance carbohydrate ingestion. Peptides (1985) 6:1205-11. doi:10.1016/0196-9781(85)90452-8.
78. Hida T, Takahashi E, Shikata K, Hirohashi T, Sawai T, Seiki T, et al. Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. J Recept Signal Transduct Res (2006) 26:147-58. doi:10.1080/10799890600623373.
79. McGowan BM, Stanley SA, White NE, Spangeus A, Patterson M, Thompson EL, et al. Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. Am J Physiol Endocrinol Metab (2007) 292:E913-9. doi:10.1152/ajpendo.00346.2006.
80. Landgraf R, Neumann ID. Vasopressin and oxytocin release within the brain:a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol (2004) 25:150-76. doi:10.1016/j.yfrne.2004.05.001.
81. Swaab DF, Nijveldt F, Pool CW. Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus. J Endocrinol (1975) 67:461-2. doi:10.1677/joe.0.0670461.
82. Poulain DA, Wakerley JB. Electrophysiology of hypothalamic magnocellular neurons secreting oxytocin and vasopressin. Neuroscience (1982) 7:773-808. doi:10.1016/0306-4522(82)90044-6.
83. Buijs RM, De Vries G, Van Leeuwen FW, Swaab DF. Vasopressin and oxytocin:distribution and putative functions in the brain. Prog Brain Res (1983) 60:115-22. doi:10.1016/S0079-6123(08)64379-4.
84. Neumann ID. Brain oxytocin:a key regulator of emotional and social behaviours in both females and males. J Neuroendocrinol (2008) 20:858-65. doi:10.1111/j.1365-2826.2008.01726.x.
85. Onaka T, Takayanagi Y, Yoshida M. Roles of oxytocin neurones in the control of stress, energy metabolism, and social behaviour. J Neuroendocrinol (2012) 24:587-98. doi:10.1111/j.1365-2826.2012.02300.x.
86. Arletti R, Benelli A, Bertolini A. Influence of oxytocin on feeding-behaviour in the rat. Peptides (1989) 10:89-93. doi:10.1016/0196-9781(89)90082-X.
87. Olson BR, Drutarosky MD, Chow MS, Hruby VJ, Stricker EM, Verbalis JG. Oxytocin and an oxytocin agonist administered centrally decrease food-intake in rats. Peptides (1991) 12:113-8. doi:10.1016/0196-9781(91)90176-P.
88. Olson BR, Drutarosky MD, Stricker EM, Verbalis JG. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatment in rats-evidence for central oxytocin inhibition of food-intake. Endocrinology (1991) 129:785-91. doi:10.1210/endo-129-2-785.
89. Olszewski PK, Klockars A, Schiöth HB, Levine AS. Oxytocin as feeding inhibitor:maintaining homeostasis in consummatory behavior. Pharmacol Biochem Behav (2010) 97:47-54. doi:10.1016/j.pbb.2010.05.026.
90. Amico JA, Vollmer RR, Cai H-M, Miedlar JA, Rinaman L. Enhanced initial and sustained intake of sucrose solution in mice with an oxytocin gene deletion. Am J Physiol Regul Integr Comp Physiol (2005) 289:R1798-806. doi:10.1152/ajpregu.00558.2005.
91. Sclafani A, Rinaman L, Vollmer RR, Amico JA. Oxytocin knockout mice demonstrate enhanced intake of sweet and nonsweet carbohydrate solutions. Am J Physiol Regul Integr Comp Physiol (2007) 292:R1828-33. doi:10.1152/ajpregu.00826.2006.
92. Camerino C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (2009) 17:980-4. doi:10.1038/oby.2009.12.
93. Douglas AJ, Meeren HK, Johnstone LE, PfaffDW, Russell JA, Brooks PJ. Stimulation of expression of the oxytocin gene in rat supraoptic neurons at parturition. Brain Res (1998) 782:167-74. doi:10.1016/S0006-8993(97)01275-4.
94. Gundlach AL, Burazin TCD, Larm JA. Distribution, regulation and role of hypothalamic galanin systems:renewed interest in a pleiotropic peptide family. Clin Exp Pharmacol Physiol (2001) 28:100-5. doi:10.1046/j.1440-1681.2001.03411.x.
95. Ebner K, Bosch OJ, Kramer SA, Singewald N, Neumann ID. Release of oxytocin in the rat central amygdala modulates stress-coping behavior and the release of excitatory amino acids. Neuropsychopharmacology (2004) 30:223-30. doi:10.1038/sj.npp.1300607.
96. Ryan PJ, Büchler E, Shabanpoor F, Hossain MA, Wade JD, Lawrence AJ, et al. Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat. Behav Brain Res (2013) 244:142-51. doi:10.1016/j.bbr.2013.01.034.
97. Kublaoui BM, Gemelli T, Tolson KP, Wang Y, Zinn AR. Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol Endocrinol (2008) 22:1723-34. doi:10.1210/me.2008-0067.
98. Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi-Syndrome-a study of 5 cases. J Clin Endocrinol Metab (1995) 80:573-9. doi:10.1210/jc.80.2.573.
99. Zhang G, Bai H, Zhang H, Dean C, Wu Q, Li J, et al. Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron (2011) 69:523-35. doi:10.1016/j.neuron.2010.12.036.
100. Holder JL, Butte NF, Zinn AR. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Mol Genet (2000) 9:101-8. doi:10.1093/hmg/9.1.101.
101. Traurig M, Mack J, Hanson RL, Ghoussaini M, Meyre D, Knowler WC, et al. Common variation in SIM1 is reproducibly associated with BMI in pima Indians. Diabetes (2009) 58:1682-9. doi:10.2337/db09-0028.
102. Lawson EA, Holsen LM, Santin M, Meenaghan E, Eddy KT, Becker AE, et al. Oxytocin secretion is associated with severity of disordered eating psychopathology and insular cortex hypoactivation in anorexia nervosa. J Clin Endocrinol Metab (2012) 97:E1898-908. doi:10.1210/jc.2012-1702.
103. Herman JP, Cullinan WE. Neurocircuitry of stress:central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci (1997) 20:78-84. doi:10.1016/S0166-2236(96)10069-2.
104. Bittencourt JC, Sawchenko PE. Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system. J Neurosci (2000) 20:1142-56.
105. Torres G, Horowitz JM, Laflamme N, Rivest S. Fluoxetine induces the transcription of genes encoding c-fos, corticotropin-releasing factor and its type 1 receptor in rat brain. Neuroscience (1998) 87:463-77. doi:10.1016/S0306-4522(98)00147-X.
106. Lenglos C, Mitra A, Guèvremont G, Timofeeva E. Sex differences in the effects of chronic stress and food restriction on body weight gain and brain expression of CRF and relaxin-3 in rats. Genes Brain Behav (2013) 12:370-87. doi:10.1111/gbb.12028.
107. McGowan BM, Stanley SA, Ghatei MA, Bloom SR. Relaxin-3 and its role in neuroendocrine function. Ann N Y Acad Sci (2009) 1160:250-5. doi:10.1111/j.1749-6632.2008.03796.x.
108. Vertes RP, Kocsis B. Brainstem-diencephalo-septohippocampal systems controlling the theta rhythm of the hippocampus. Neuroscience (1997) 81:893-926.
109. Pan WX, McNaughton N. The role of the medial supramammillary nucleus in the control of hippocampal theta activity and behaviour in rats. Eur J Neurosci (2002) 16:1797-809. doi:10.1046/j.1460-9568.2002.02267.x.
110. Buzsaki G. Theta oscillations in the hippocampus. Neuron (2002) 33:325-40. doi:10.1016/S0896-6273(02)00586-X.
111. Hasselmo ME. What is the function of hippocampal theta rhythm? Linking behavioral data to phasic properties of field potential and unit recording data. Hippocampus (2005) 15:936-49. doi:10.1002/hipo.20116.
112. Vertes RP. Hippocampal theta rhythm:a tag for short-term memory. Hippocampus (2005) 15:923-35. doi:10.1002/hipo.20118.
113. Kahana MJ, Sekuler R, Caplan JB, Kirschen M, Madsen JR. Human theta oscillations exhibit task dependence during virtual maze navigation. Nature (1999) 399:781-4. doi:10.1038/21645.
114. Bland BH, Oddie SD. Theta band oscillation and synchrony in the hippocampal formation and associated structures:the case for its role in sensorimotor integration. Behav Brain Res (2001) 127:119-36. doi:10.1016/S0166-4328(01)00358-8.
115. Cruikshank LC, Singhal A, Hueppelsheuser M, Caplan JB. Theta oscillations reflect a putative neural mechanism for human sensorimotor integration. J Neurophysiol (2012) 107:65-77. doi:10.1152/jn.00893.2010.
116. Nunez A, Cervera-Ferri A, Olucha-Bordonau FE, Ruiz-Torner A, Teruel V. Nucleus incertus contribution to hippocampal theta rhythm generation. Eur J Neurosci (2006) 23:2731-8. doi:10.1111/j.1460-9568.2006.04797.x.
117. Nakamura K. Central circuitries for body temperature regulation and fever. Am J Physiol Regul Integr Comp Physiol (2011) 301:R1207-28. doi:10.1152/ajpregu.00109.2011.
118. Mallick HN, Kumar VM. Basal forebrain thermoregulatory mechanism modulates auto-regulated sleep. Front Neurol (2012) 3:102. doi:10.3389/fneur.2012.00102.
119. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature (2005) 437:1257-63. doi:10.1038/nature04284.
120. Smith CM, Hosken IT, Sutton SW, Lawrence AJ, Gundlach AL. Relaxin-3 null mutation mice display a circadian hypoactivity phenotype. Genes Brain Behav (2012) 11:94-104. doi:10.1111/j.1601-183X.2011.00730.x.
121. Smith CM, Hosken IT, Downer NL, Chua BE, Hossain MA, Wade JD, et al. Pharmacological activation of RXFP3 is not orexigenic in C57BL/6J mice. Proceedings of 6th International Conference on Relaxin and Related Peptides. Florence:Florence University Press (Forthcoming 2013).
122. Smith CM, Lawrence AJ, Sutton SW, Gundlach AL. Behavioral phenotyping of mixed background (129S5:B6) relaxin-3 knockout mice. Ann N Y Acad Sci (2009) 1160:236-41. doi:10.1111/j.1749-6632.2009.03953.x.
123. Sutton SW, Shelton J, Smith CM, Williams J, Yun S, Motley T, et al. Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system. Ann N Y Acad Sci (2009) 1160:242-9. doi:10.1111/j.1749-6632.2008.03812.x.
124. Hosken IT, Smith CM, Blasiak A, Gundlach AL. Elimination of RXFP3 signalling causes reduced circadian voluntary wheel running in mice:implications for relaxin-3 networks in arousal and sleep control. J Sleep Res (2012) 21(Suppl 1):120.
125. Hosken IT, Smith CM, Chua BE, Gundlach AL. Consequences of relaxin-3 null mutation in mice on food-entrainable arousal. Proceedings of 6th International Conference on Relaxin and Related Peptides. Florence:Florence University Press (Forthcoming 2013).
126. Dun SL, Brailoiu E, Wang Y, Brailoiu GC, Liu-Chen LY, Yang J, et al. Insulin-like peptide 5:expression in the mouse brain and mobilization of calcium. Endocrinology (2006) 147:3243-8. doi:10.1210/en.2006-0237.
127. Liu C, Kuei C, Sutton S, Chen J, Bonaventure P, Wu J, et al. INSL5 is a high affinity specific agonist for GPCR142 (GPR100). J Biol Chem (2005) 280:292-300.
128. Mashima H, Ohno H, Yamada Y, Sakai T, Ohnishi H. INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors. Biochem Biophys Res Commun (2013) 432:586-92. doi:10.1016/j.bbrc.2013.02.042.